Skip to main content
NCBI home page
Nature Portfolio logoLink to Nature Portfolio
. 2023 Dec 4;30(3):907. doi: 10.1038/s41591-023-02735-4

Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping

Sylvan C Baca 1,2,3, Ji-Heui Seo 1,2, Matthew P Davidsohn 1,2, Brad Fortunato 1,2,3, Karl Semaan 1,3, Shahabbedin Sotudian 1,2,3, Gitanjali Lakshminarayanan 1,2, Miklos Diossy 4, Xintao Qiu 1,2, Talal El Zarif 1,2, Hunter Savignano 1,2, John Canniff 1,2, Ikenna Madueke 1,2, Renee Maria Saliby 1,2, Ziwei Zhang 1,2,3, Rong Li 1,2, Yijia Jiang 1,2, Len Taing 1,2, Mark Awad 5, Cindy H Chau 6, James A DeCaprio 1,7, William D Figg 6, Tim F Greten 8, Aaron N Hata 9,10, F Stephen Hodi 1, Melissa E Hughes 1, Keith L Ligon 1,11, Nancy Lin 1, Kimmie Ng 1, Matthew G Oser 1, Catherine Meador 9,10, Heather A Parsons 1, Mark M Pomerantz 1,2, Arun Rajan 12, Jerome Ritz 1, Manisha Thakuria 13,14, Sara M Tolaney 1, Patrick Y Wen 15,16, Henry Long 1,2, Jacob E Berchuck 1,2, Zoltan Szallasi 4,17,18, Toni K Choueiri 1, Matthew L Freedman 1,2,3,✉
PMCID: PMC10957463  PMID: 38049623

Correction to: Nature Medicine 10.1038/s41591-023-02605-z, published online 21 October 2023.

This article was originally published under a standard Springer Nature license (© The Author(s), under exclusive licence to Springer Nature America, Inc.); it is now available as an open-access paper under a Creative Commons Attribution 4.0 International license, © The Author(s). The error has been corrected in the HTML and PDF versions of the article.

Articles from Nature Medicine are provided here courtesy of Nature Publishing Group

RESOURCES